Pfizer to pay record $2.3 billion for promoting drugs unlawfully
Sep 03, 2009
Pfizer Inc., the largest drug maker in the world, will pay a record $2.3 billion in criminal and civil fines over illegal promotions of four prescription drugs.
Independent review comes up clean, Sunrise says
By
Haymarket Media
Oct 02, 2007
An independent review panel charged with investigating allegations of financial wrongdoing at Sunrise Senior Living Inc. failed to find any illegal activity, the company disclosed.
Report: Reverse mortgages may not be the answer for long-term care
By
Haymarket Media
Mar 19, 2004
Linking reverse mortgages with long-term care insurance may not be the answer to solve financial crises, a new report released by Health Strategies, Inc. says.
Infection prevention product released
Jun 14, 2016
VidaShield from American Green Technology debuted at the APIC 2016 conference.
REITs to shed skilled sites
By
Tim Mullaney
Jun 01, 2013
Large real estate investment trusts are looking to get out of the skilled nursing sector, according to the Wall Street Journal.
Workouts can hasten decline
By
Marty Stempniak
Jun 08, 2018
Moderate exercise may hasten Alzheimer’s if done regularly after diagnosis, a new study suggests. Oxford researchers found people with mild to moderate dementia who worked out in a gym twice weekly...
Lifetechniques touts electronic pillbox study
May 14, 2008
Older adults following a medication regimen are less likely to miss doses when reminded by an electronic pillbox that both beeps at the appointed drug-taking time and announces the number of pills to take,...
Bush vetoes stem cell research bill
By
Haymarket Media
Jun 21, 2007
President Bush late Wednesday vetoed a stem cell research bill. It is the second year in a row he has nixed legislation that would allow researchers access to more stem cell lines.
Gentell’s Fastcare now includes QAPI reporting
Jan 06, 2015
Gentell Inc. has announced its Fastcare wound documentation and ordering now includes Quality Assurance Performance Improvement reporting capabilities.
Study evaluates heart failure device
May 03, 2017
2breathe Technologies and its U.S. subsidiary Resperate Inc. have announced the publication of an article evaluating its hypertension treatment device, RESPeRATE.